Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Renal cell carcinoma treatment, Renal and related cancers, Bladder and Urothelial Cancer Treatments, and Prostate Cancer Diagnosis and Treatment.
Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity.
Supplementary Figures from Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity
Table 2 from Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity
Figure 2 from Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity
Figure 3 from Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity
Data from Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity
Figure 5 from Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity
Supplementary Tables from Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity
Table 1 from Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity
Supplementary Tables from Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity
Figure 6 from Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity
Supplementary Figures from Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity
Figure 1 from Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity
Figure 4 from Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity
Supplementary Tables from Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity
Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study
Diagnostic Performance and Safety of Positron Emission Tomography with 18F-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prostate Cancer: Results from a Phase 3, Prospective, Multicentre Study (LIGHTHOUSE)
Diagnostic Performance and Safety of <sup>18</sup> F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT)
Comparison of Multiple Segmentation Methods for Volumetric Delineation of Primary Prostate Cancer with Prostate-Specific Membrane Antigen–Targeted<sup>18</sup>F-DCFPyL PET/CT
Characterizing Tumor Thrombus Arising from Non–Clear Cell Renal Cell Carcinoma
Novel PET imaging methods for prostate cancer
Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade
The Future of Perioperative Therapy in Advanced Renal Cell Carcinoma: How Can We Prosper?
Tumour immune microenvironment in primary and metastatic papillary renal cell carcinoma
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms
Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States
Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging
Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis